Inflammatory markers in men with angiographically documented coronary heart disease

N Rifai1, R Joubran, H Yu

  • 1Department of Laboratory Medicine, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. rifai@a1.tch.harvard.edu

Clinical Chemistry
|November 2, 1999
PubMed

Insights

Inflammation markers like C-reactive protein (CRP), serum amyloid A (SAA), and interleukin-6 (IL-6) are elevated in coronary heart disease (CHD) patients. However, these markers do not correlate with the severity of coronary artery obstruction.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Biochemistry

Background:

  • Atherosclerosis is increasingly recognized as a chronic inflammatory condition.
  • Investigating inflammatory markers in coronary heart disease (CHD) is crucial for understanding disease mechanisms.

Purpose of the Study:

  • To examine concentrations of key inflammation markers in men with CHD compared to controls.
  • To assess the association between these inflammation markers and the severity of coronary artery disease.

Main Methods:

  • Measured serum concentrations of C-reactive protein (CRP), serum amyloid A (SAA), interleukin-6 (IL-6), and soluble intracellular adhesion molecule (sICAM-1).
  • Compared 100 men with angiographically confirmed CHD against 100 matched controls.
  • Correlated marker levels with the degree of coronary artery obstruction (single, double, or triple vessel disease).

Main Results:

  • Significantly elevated CRP, SAA, and IL-6 levels were observed in CHD patients versus controls.
  • These elevations persisted after adjusting for major cardiovascular risk factors.
  • No significant difference in sICAM-1 was found, and no markers correlated with disease severity.

Conclusions:

  • CRP, SAA, and IL-6 are elevated in CHD, suggesting a systemic inflammatory component.
  • These markers may indicate a diffuse atherosclerotic process rather than localized lesion severity.
  • Further research is needed to clarify the role of these inflammatory markers in atherosclerosis progression.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...